BLIV vs BMR

The Advanced Deterministic Scorecard reveals a Piotroski F-Score of 5/9, indicating stable but not strong financial health, while the absence of an Altman Z-Score prevents a full distress risk assessment. Despite a strong Current Ratio of 24.19 and moderate gross margin of 48.98%, the company is deeply unprofitable with an operating margin of -1507.43% and ROE of -109.04%. Revenue has collapsed by 54.20% year-over-year, and valuation multiples like Price/Sales of 22.48 are extremely high for a shrinking, unprofitable business. The stock has underperformed over the long term despite a short-term 6M gain, and peer comparisons show similar distressed profiles with no clear catalysts.

The Advanced Deterministic Scorecard reveals a weak financial health profile with a Piotroski F-Score of 4/9, indicating borderline stability, and no available Altman Z-Score prevents a full distress risk assessment. Despite a strong gross margin of 90.23% and a low Debt/Equity ratio of 0.01, the company is deeply unprofitable with negative operating and net margins of -320.04% and -146.06%, respectively. Revenue growth is minimal at 6.70% YoY, while market performance has been severely negative, with a 1-year return of -52.7%. Valuation metrics like Price/Sales of 9.47 appear high relative to peers and fundamentals, suggesting limited upside without a turnaround.